Bullish Case: Call volume leads puts by 75% and Helium sees bullish risk 11% above bearish. Q2 raised FY guidance despite a soft consumer, Autoship/subscription stickiness (84% of sales) supports recurring revenue, and the price-density mass concentrates near $20.5–21.5 with a meaningful upside shoulder to $28–30. Backwardated IV (~62% Sep vs ~47% Oct) offers premium income while owning cheap January/2027 upside calls.

Bearish Case: Price sits at $20.62, down sharply from prior months, with flat action and 0th-percentile options liquidity. Q2 shares slid on treat-spending pullback; discretionary demand is fragile. The market PDF puts heavy weight at $20–21.5 with fat tails below $18, and Helium's own forecast is -1.42% with a 0.0 accuracy correlation. P/B of 276 leaves little valuation cushion.

Potential Outcomes:

1. 40% Range-bound $19–22 through Dec: Q3 in-line, IV compresses from ~62% to ~47% Oct level. Falsified by a close outside the band.
2. 25% Grind to $23–26: Autoship growth + retail-media momentum (Chewy Ads) re-rate shares modestly into Jan earnings.
3. 20% Break lower to $16–18: treat-spending cuts deepen, put wing IV (46–55%) spikes; Oct 20-strike puts active.
4. 10% Rally to $27–30 on upgrade/squeeze; Dec 18 25C flows already hint at this.
5. 5% Tail <$15 or >$32 on macro/competitive shock.

September 22, 2026